NCT05896059 2023-06-09A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLCZhejiang Cancer HospitalPhase 2 Unknown21 enrolled
NCT04933175 2021-06-21Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung CancerFujian Provincial HospitalPhase 2 Unknown50 enrolled